Skip to main content
SpringerLink
Log in

New Developments in Antibacterial Chemotherapy for Bacterial Keratitis

  • Chapter
  • First Online:
Corneal Disease

Abstract

The treatment of bacterial keratitis depends on identifying the causative agent and selecting an appropriate antimicrobial.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bharathi MJ et al (2007) Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 14(2):61–69

    Article  PubMed  Google Scholar 

  2. Waring GO, Laibson PR (1977) A systematic method of drawing corneal pathologic conditions. Arch Ophthalmol 95(9):1540–1542

    Article  PubMed  CAS  Google Scholar 

  3. Liesegang TJ (1997) Contact lens-related microbial keratitis: part I: epidemiology. Cornea 16(2):125–131

    PubMed  CAS  Google Scholar 

  4. Sharma S et al (2003) Trends in contact lens-associated microbial keratitis in Southern India. Ophthalmology 110(1):138–143

    Article  PubMed  Google Scholar 

  5. Bourcier T et al (2003) Bacterial keratitis: predisposing factors, clinical and microbiological review of 300 cases. Br J Ophthalmol 87(7):834–838

    Article  PubMed  CAS  Google Scholar 

  6. Schaefer F et al (2001) Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 85(7):842–847

    Article  PubMed  CAS  Google Scholar 

  7. Lam DS et al (2002) Incidence and risk factors for microbial keratitis in Hong Kong: comparison with Europe and North America. Eye (Lond) 16(5):608–618

    Article  CAS  Google Scholar 

  8. Fahmy JA, Moller S, Bentzon MW (1974) Bacterial flora of the normal conjunctiva. I. Topographical distribution. Acta Ophthalmol (Copenh) 52(6):786–800

    Article  CAS  Google Scholar 

  9. Fukuda M et al (2002) Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops. Cornea 21(7 Suppl):S86–S89

    Article  PubMed  Google Scholar 

  10. Kaye S et al (2010) Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis. Invest Ophthalmol Vis Sci 51(1):362–368

    Article  PubMed  Google Scholar 

  11. Sueke H et al (2010) Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51(5):2519–2524

    Article  PubMed  Google Scholar 

  12. Tuft SJ, Matheson M (2000) In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol 84(7):687–691

    Article  PubMed  CAS  Google Scholar 

  13. Bharathi MJ et al (2003) Epidemiology of bacterial keratitis in a referral centre in south India. Indian J Med Microbiol 21(4):239–245

    PubMed  CAS  Google Scholar 

  14. McDonnell PJ (1996) Empirical or culture-guided therapy for microbial keratitis? A plea for data. Arch Ophthalmol 114(1):84–87

    Article  PubMed  CAS  Google Scholar 

  15. Kaye SB et al (2003) Simplifying collection of corneal specimens in cases of suspected bacterial keratitis. J Clin Microbiol 41(7):3192–3197

    Article  PubMed  Google Scholar 

  16. Itahashi M et al (2010) Detection and quantification of pathogenic bacteria and fungi using real-time polymerase chain reaction by cycling probe in patients with corneal ulcer. Arch Ophthalmol 128(5):535–540

    Article  PubMed  CAS  Google Scholar 

  17. Subrayan V et al (2010) Assessment of polymerase chain reaction in the detection of Pseudomonas aeruginosa in contact lens-induced severe infectious keratitis. Eye Contact Lens 36(4):201–203

    Article  PubMed  Google Scholar 

  18. Kaye SB et al (2009) Concentration and bioavailability of ciprofloxacin and teicoplanin in the cornea. Invest Ophthalmol Vis Sci 50(7):3176–3184

    Article  PubMed  Google Scholar 

  19. Urtti A (2006) Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58(11):1131–1135

    Article  PubMed  CAS  Google Scholar 

  20. Baum J, Barza M (2000) The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970–2000. Cornea 19(5):659–672

    Article  PubMed  CAS  Google Scholar 

  21. Goldstein MH, Kowalski RP, Gordon YJ (1999) Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106(7):1313–1318

    Article  PubMed  CAS  Google Scholar 

  22. Garg P, Sharma S, Rao GN (1999) Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 106(7):1319–1323

    Article  PubMed  CAS  Google Scholar 

  23. Moshirfar M et al (2006) Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg 32(3):515–518

    Article  PubMed  Google Scholar 

  24. Jhanji V et al (2007) Fourth-generation fluoroquinolone-resistant bacterial keratitis. J Cataract Refract Surg 33(8):1488–1489

    Article  PubMed  Google Scholar 

  25. Park SH et al (2009) The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea 28(1):68–72

    Article  PubMed  Google Scholar 

  26. Kim DH, Stark WJ, O’Brien TP (2005) Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. Curr Med Res Opin 21(1):93–94

    Article  PubMed  CAS  Google Scholar 

  27. Sugioka K et al (2009) Intraocular penetration of sequentially instilled topical moxifloxacin, gatifloxacin, and levofloxacin. Clin Ophthalmol 3:553–557

    Article  PubMed  CAS  Google Scholar 

  28. Yagci R et al (2007) Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model. Eye (Lond) 21(7):990–994

    Article  CAS  Google Scholar 

  29. Alfonso EC et al (1990) In vitro toxicity of gentamicin to corneal epithelial cells. Cornea 9(1):55–61

    Article  PubMed  CAS  Google Scholar 

  30. Baum J (1982) Treatment of bacterial ulcers of the cornea in the rabbit: a comparison of administration by eye drops and subconjunctival injections. Trans Am Ophthalmol Soc 80:369–390

    PubMed  CAS  Google Scholar 

  31. Jenkins CD et al (1996) Comparative intraocular penetration of topical and injected cefuroxime. Br J Ophthalmol 80(8):685–688

    Article  PubMed  CAS  Google Scholar 

  32. Karpecki P (2009) Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: a multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. Clin Ther 31(3):514–526

    Article  PubMed  CAS  Google Scholar 

  33. Proksch JW et al (2009) Ocular pharmacokinetics of besifloxacin following topical administration to rabbits, monkeys, and humans. J Ocul Pharmacol Ther 25(4):335–344

    Article  PubMed  CAS  Google Scholar 

  34. Sanders ME et al (2011) Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of Pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Cornea 30(1):83–90

    Article  PubMed  Google Scholar 

  35. Sanders ME et al (2009) Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Cornea 28(9):1055–1060

    Article  PubMed  Google Scholar 

  36. Pankey GA (2005) Tigecycline. J Antimicrob Chemother 56(3):470–480

    Article  PubMed  CAS  Google Scholar 

  37. Moellering RC (2003) Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med 138(2):135–142

    PubMed  CAS  Google Scholar 

  38. Ekdawi NS (2005) Topical linezolid in Streptococcus pneumoniae corneal ulcer model in rabbits. Invest Ophthalmol Vis Sci 46(5):4910

    Google Scholar 

  39. Saleh M (2010) Ocular penetration of topically applied linezolid in a rabbit model. J Cataract Refract Surg 36(3):488–492

    Article  PubMed  Google Scholar 

  40. Baldwin CM, Lyseng-Williamson KA, Keam SJ (2008) Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs 68(6):803–838

    Article  PubMed  CAS  Google Scholar 

  41. Manav C (2004) Comparison of intravitreal ceftazidime and meropenem in treatment of experimental pseudomonal posttraumatic endophthalmitis in a rabbit model. J Appl Res 4(2):337–345

    Google Scholar 

  42. Schauersberger J et al (1999) Penetration and decay of meropenem into the human aqueous humor and vitreous. J Ocul Pharmacol Ther 15(5):439–445

    Article  PubMed  CAS  Google Scholar 

  43. Moellering RC Jr, Wennersten C, Weinberg AN (1971) Synergy of penicillin and gentamicin against Enterococci. J Infect Dis 124(Suppl):S207–S209

    Article  PubMed  CAS  Google Scholar 

  44. Winstanley TG, Hastings JG (1990) Synergy between penicillin and gentamicin against enterococci. J Antimicrob Chemother 25(4):551–560

    Article  PubMed  CAS  Google Scholar 

  45. Friedland IR, Klugman KP (1992) Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 339(8790):405–408

    Article  PubMed  CAS  Google Scholar 

  46. Sueke H et al (2010) An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis. Invest Ophthalmol Vis Sci 51(8):4151–4155

    Article  PubMed  Google Scholar 

  47. Kearns VR, Williams RL (2009) Drug delivery systems for the eye. Expert Rev Med Devices 6(3):277–290

    Article  PubMed  CAS  Google Scholar 

  48. Behar-Cohen F (2002) Drug delivery systems to target the anterior segment of the eye: fundamental bases and clinical applications. J Fr Ophtalmol 25(5):537–544

    PubMed  CAS  Google Scholar 

  49. Luchs JI, Nelinson DS, Macy JI (2010) Efficacy of hydroxypropyl cellulose ophthalmic inserts (LACRISERT) in subsets of patients with dry eye syndrome: findings from a patient registry. Cornea 29(12):1417–1427

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. St. Paul’s Eye Unit, Royal Liverpool University Hospital, 8Z Link, Prescot Street, Liverpool, L7 8XP, UK

    H. Sueke, J. Shankar, R. Gilbert & Stephen B. Kaye

  2. Department of Microbiology, Royal Liverpool University Hospital, 7th floor, Duncan Building, Daulby street, Liverpool, L69 3GA, UK

    T. J. Neal

  3. Institute of Integrative Biology, University of Liverpool, Crown street, Liverpool, L69 7ZB, UK

    M. Horsburgh

Authors
  1. H. Sueke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Shankar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. J. Neal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Horsburgh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Gilbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Stephen B. Kaye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Sueke .

Editor information

Editors and Affiliations

  1. University Eye Hospital, University of Freiburg, Killianstr. 5, Freiburg, 79106, Germany

    Thomas Reinhard

  2. Moorfields Eye Hospital, City Road 162, London, EC1V 2PD, United Kingdom

    Frank Larkin

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sueke, H., Shankar, J., Neal, T.J., Horsburgh, M., Gilbert, R., Kaye, S.B. (2013). New Developments in Antibacterial Chemotherapy for Bacterial Keratitis. In: Reinhard, T., Larkin, F. (eds) Corneal Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28747-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-28747-3_2

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-28746-6

  • Online ISBN: 978-3-642-28747-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation